Auteurs
Keywords (en)
Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Pierre Pollak44
Levodopa (adverse effects)41
Pierre Pollak Sauf Levodopa (adverse effects)" 35
Levodopa (adverse effects) Sauf Pierre Pollak" 32
Pierre Pollak Et Levodopa (adverse effects) 9
Pierre Pollak Ou Levodopa (adverse effects) 76
Corpus679
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
000303 Ebba Lohmann [France] ; Marie-Laure Welter [France] ; Valérie Fraix [France] ; Paul Krack [France] ; Suzanne Lesage [France] ; Sophie Laine [France] ; Marie-Laure Tanguy [France] ; Jean-Luc Houeto [France] ; Valérie Mesnage [France] ; Pierre Pollak [France] ; Alexandra Durr [France] ; Yves Agid [France] ; Alexis Brice [France]Are parkin patients particularly suited for deep‐brain stimulation?
000414 Serge Pinto [France, Royaume-Uni] ; Michèle Gentil [France] ; Paul Krack [France] ; Paul Sauleau [France] ; Valérie Fraix [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France]Changes induced by levodopa and subthalamic nucleus stimulation on parkinsonian speech
000470 Paul Krack [France] ; Valérie Fraix [France] ; Alexandre Mendes [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France]Postoperative management of subthalamic nucleus stimulation for Parkinson's disease
000536 Christine Dentresangle [France] ; Laurent Veyre [France] ; Didier Le Bars [France] ; Christian Pierre [France] ; Frank Lavenne [France] ; Pierre Pollak [France] ; Jeanine Guerin [France] ; Jean-Claude Froment [France] ; Emmanuel Brousolle [France]Striatal D2 dopamine receptor status in Parkinson's disease: An [18F]dopa and [11C]Raclopride PET study
000545 Yves Agid [France] ; E. Ahlskog [France] ; A. Albanese [France] ; D. Calne [France] ; T. Chase [France] ; J. De Yebenes [France] ; S. Factor [France] ; S. Fahn [France] ; O. Gershanik [France] ; C. Goetz [France] ; W. Koller [France] ; M. Kurth [France] ; A. Lang [France] ; A. Lees [France] ; P. Lewitt [France] ; D. Marsden [France] ; E. Melamed [France] ; P. P. Michel [France] ; Y. Mizuno [France] ; J. Obeso [France] ; W. Oertel [France] ; W. Olanow [France] ; Werner Poewe [France] ; Pierre Pollak [France] ; S. Przedzorski [France] ; N. Quinn [France] ; R. Raisman-Vozari [France] ; A. Rajput [France] ; F. Stocchi [France] ; E. Tolosa [France]Levodopa in the treatment of Parkinson's disease: A consensus meeting viewpoint
000567 Paul Krack [France] ; Pierre Pollak [France] ; Patricia Limousin [France] ; Dominique Hoffmann [France] ; Abdelhamid Benazzouz [France] ; Alim-Louis Benabid [France]Inhibition of levodopa effects by internal pallidal stimulation
000603 Limousin [France] ; Pierre Pollak [France] ; Dominique Hoffmann [France] ; Abdelhamid Benazzouz [France] ; Jean Edmond Perret [France] ; Alim-Louis Benabid [France]Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients
000647 H. Allain [France] ; Pierre Pollak [France] ; H. C. Neukirch [France]Symptomatic effect of selegiline in De Novo Parkinsonian patients
000652 Jean-Fra Ois De Saint Victor [France] ; Pierre Pollak [France] ; Claire-Lise Gervason [France] ; Jean Perret [France]Levodopa‐induced diphasic dyskinesias improved by subcutaneous apomorphine
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024